New benefits for patients of joint replacement surgeries found in common bone drug
December 7, 2011
New research from scientists at the University of Oxford suggests that people who have undergone joint replacement surgeries may benefit from a common bone density drug in order to avoid or ward off revision surgery for longer.
To test this, researchers looked at data from the General Practice Research Data, which holds the medical records of 3 million UK citizens. From here, they looked for patients over 40 who had knee or hip replacement surgeries due to osteoarthritis. Researchers checked on the patients progress for up to 15 years after their surgeries.
Scientists then broke these people into three groups – one group took the drug at least 6 months prior to their surgeries, the second group never took the drug and the third started taking the medication after their surgeries.
From the results, researchers found that people who took the drug had a lower revision rate after five years over non-users, while users also increased their implant survival rate two times more than non-users.
More seniors are having such surgeries as a way to stay healthy and remain at home as they age. Although many times these operations are successful, sometimes implants can pop out – leaving a senior stuck. Those living alone may want to install a medical alert system into their homes, so if they do fall, they have access to help.